<DOC>
	<DOCNO>NCT03003572</DOCNO>
	<brief_summary>Primary Sjögren 's syndrome ( pSS ) affect various organ , sometimes lead life-threatening condition always responsible decrease quality life . Its evolution chronic , flare relapse , need reliable biomarkers carry routinely major patient ' follow-up . Because existence autoreactive immunoglobulin E ( IgE ) autoimmune disease , recently describe role anti-Ro/SSA antibody induce interferon alpha ( IFNα ) signal specific pharmacologic property IgE , anti-Ro/SSA IgE interesting biomarker determine pSS 's activity . The aim study evaluate whether proportion anti-Ro/SSA IgE positive patient higher patient active disease ( i.e . Eular Sjögren Syndrome Disease Activity Index≥ 5 ) . All consecutive patient pSS ( new already know diagnosis ) include , Anti-Ro/SSA IgE titer determine , disease 's feature collect ( include Eular Sjögren Syndrome Disease Activity Index/Eular Sjogren 's Syndrome Patient Reported Index ) .</brief_summary>
	<brief_title>Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen 's Syndrome 's Disease Activity</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Sjogren 's Syndrome</mesh_term>
	<criteria>Age &gt; 18 year Primary Sjögren 's syndrome accord AmericanEuropean Consensus Criteria ) Informed sign study consent form Secondary Sjögren 's syndrome Other systemic autoimmune disease ( e.g . rheumatoid arthritis , AntiNeutrophil Antibodies ( ANCA ) associate vasculitis , mixed connective tissue disease… ) Incapacity refusal sign inform consent form Incapacity refusal perform followup examination require study Has receive abatacept , sifalimumab , rontalizumab , anifrolumab , belimumab , Tumor Necrosis Factor ( TNF ) antagonists interferon 6 month prior inclusion Has current sign symptom active infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Sjögren 's syndrome</keyword>
	<keyword>Immunoglobulin E</keyword>
	<keyword>Anti-Ro/SSA</keyword>
	<keyword>Autoimmune disease</keyword>
	<keyword>Biomarker</keyword>
</DOC>